% alzhub.org library filter % Source: https://alzhub.org/research?author=Altuna+M&institution=I123044942 % 6 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{videla2025-40528282, author = {Videla, L. and Benejam, B. and Barroeta, I. and Fernandez, S. and Altuna, M. and Arranz, J. and Í, Rodríguez-Baz and Arriola-Infante, J. E. and others}, title = {{The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2025}, doi = {10.1002/alz.70259}, pmid = {40528282}, url = {https://doi.org/10.1002/alz.70259} } @article{videla2022-35930282, author = {Videla, L. and Benejam, B. and Pegueroles, J. and Carmona-Iragui, M. and Padilla, C. and Fernández, S. and Barroeta, I. and Altuna, M. and others}, title = {{Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome}}, journal = {JAMA network open}, year = {2022}, doi = {10.1001/jamanetworkopen.2022.25573}, pmid = {35930282}, url = {https://doi.org/10.1001/jamanetworkopen.2022.25573} } @article{delaby2020-32514050, author = {Delaby, C. and Alcolea, D. and Carmona-Iragui, M. and Illán-Gala, I. and Morenas-Rodríguez, E. and Barroeta, I. and Altuna, M. and Estellés, T. and others}, title = {{Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders}}, journal = {Scientific reports}, year = {2020}, doi = {10.1038/s41598-020-66090-x}, pmid = {32514050}, url = {https://doi.org/10.1038/s41598-020-66090-x} } @article{montal2021-34309066, author = {Montal, V. and Barroeta, I. and Bejanin, A. and Pegueroles, J. and Carmona-Iragui, M. and Altuna, M. and Benejam, B. and Videla, L. and others}, title = {{Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome}}, journal = {Annals of neurology}, year = {2021}, doi = {10.1002/ana.26178}, pmid = {34309066}, url = {https://doi.org/10.1002/ana.26178} } @article{lleo2021-34183050, author = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others}, title = {{VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00861-0}, pmid = {34183050}, url = {https://doi.org/10.1186/s13195-021-00861-0} } @article{moreau2022-35740400, author = {Moreau, M. and Carmona-Iragui, M. and Altuna, M. and Dalzon, L. and Barroeta, I. and Vilaire, M. and Durand, S. and Fortea, J. and others}, title = {{DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients}}, journal = {Biomedicines}, year = {2022}, doi = {10.3390/biomedicines10061380}, pmid = {35740400}, url = {https://doi.org/10.3390/biomedicines10061380} }